Clinical Trials Directory

Trials / Completed

CompletedNCT00813748

Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair Dosing

Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair(R) Dosing

Status
Completed
Phase
Study type
Observational
Enrollment
118 (actual)
Sponsor
Genentech, Inc. · Industry
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This study will establish a clinical data and serum repository of anaphylaxis cases associated with Xolair administration and control patients who have received Xolair without associated anaphylaxis. This is an observational repository and not an investigational clinical trial. Associated with the repository is an optional skin testing substudy.

Conditions

Interventions

TypeNameDescription
DRUGXolair

Timeline

Start date
2009-03-01
Primary completion
2014-01-01
Completion
2014-01-01
First posted
2008-12-23
Last updated
2017-07-11
Results posted
2015-09-15

Locations

7 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00813748. Inclusion in this directory is not an endorsement.

Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair (NCT00813748) · Clinical Trials Directory